MEI Pharma Inc (MEIP)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

11455 EL CAMINO REAL SAN DIEGO, CA 92130

MEI Pharma, Inc. is a late-stage pharmaceutical company focused on developing potential new therapies for cancer. MEI Pharma's portfolio of drug candidates contains four clinical-stage assets, including zandelisib, currently in an ongoing Phase 2 clinical trial which may support an accelerated approval marketing application with the U.S. Food and Drug Administration. Each of MEI Pharma's pipeline candidates leverages a different mechani® of action with the objective of developing therapeutic options that are: (1) differentiated, (2) address unmet medical needs and (3) deliver improved benefit to patients either as standalone treatments or in combination with other therapeutic options.

Data as of 2021-07-19 08:32:18 -0400
Market Cap299.494 Million Shares Outstanding112.592 Million Avg 30-day Volume579.976 Thousand
P/E Ratio-4.72873 Dividend Yield EPS-0.565
Price/Sales7.32 Debt to Equity4.14 EBITDA-44.004 Million
Price to Book Value6.66 Forward PE0.03 Enterprise Value134.87 Million
Total Cash164.624 Million Current Debt33.376 Million Gross Profit39.033 Million
BETA0.90822 52-week High/Low4.58 / 2.29 Next Earnings Date2021-09-08 Price to Cash FLow (P/CF) -10.2431
Data provided by IEX Cloud
View SEC Filings from MEIP instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 2 0.0% 2 (0.12%) 2 (0.12%) 0.0%
Funds Holding: 105 110 -4.55% 36 (2.11%) 37 (2.15%) -2.7%
13F shares: 80.841 Million 75.569 Million 6.98% 38.995 Million 36.082 Million 8.07%
% Ownership 71.8411 67.1589 6.97% 34.6538 32.0665 8.07%
New Positions: 12 15 -20.0% 3 5 -40.0%
Increased Positions 34 49 -30.61% 11 17 -35.29%
Closed Positions 16 10 60.0% 4 4 0.0%
Reduced Positions 33 24 37.5% 16 11 45.45%
Total Calls 997.642 Thousand 1.188 Million -16.02% 44.3 Thousand 25.7 Thousand 72.37%
Total Puts 15.83 Thousand 92.605 Thousand -82.91% 0
PUT/CALL Ratio 0.02 0.08 -75.0% 0.0 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MEIP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MEIP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GOLD DANIEL P PHD CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
3,582,812 2021-07-01 2

BALTIC CHARLES V. III

  • Director
160,000 2021-07-01 1

WHITE CHRISTINE ANNA

  • Director
160,000 2021-07-01 1

REYNOLDS THOMAS C

  • Director
160,000 2021-07-01 1

GLOVER NICHOLAS

  • Director
160,000 2021-07-01 1

URSO DAVID M CHIEF OPERATING OFFICER & GC

  • Officer
2,001,781 2021-07-01 1

CLEMENS KEVAN

  • Director
172,667 2021-07-01 1

DRAZBA BRIAN G. CHIEF FINANCIAL OFFICER

  • Officer
860,000 2021-07-01 1

DRISCOLL FREDERICK W

  • Director
173,333 2021-07-01 2

HOWSON TAMAR D

  • Director
160,000 2021-07-01 1

COHEN CHERYL

  • Director
130,000 2021-07-01 1

GHALIE RICHARD G CHIEF MEDICAL OFFICER

  • Officer
895,000 2021-07-01 3

MASS ROBERT D. CHIEF MEDICAL OFFICER

  • Officer
0 2020-07-02 0

RUECKERT WILLIAM DODGE

  • Director
0 2019-07-01 0

ZECH THOMAS M. CHIEF FINANCIAL OFFICER

  • Officer
0 2016-08-05 0

CANN LEAH RUSH

  • Director
0 2016-07-29 0

VIVO VENTURES V, LLC

  • 10% Owner
No longer subject to file 2015-11-05 0

VIVO VENTURES VII, LLC

  • 10% Owner
No longer subject to file 2015-11-05 0

NEW LEAF VENTURES II, L.P.

NEW LEAF VENTURE ASSOCIATES II, L.P.

NEW LEAF VENTURE MANAGEMENT II, L.L.C.

CHAMBON PHILIPPE O.

HUNT RONALD

LATHI VIJAY K

DELAGARDELLE JEANI

RATCLIFFE LIAM

  • 10% Owner
No longer subject to file 2015-03-24 0

NEW LEAF VENTURES II, L.P.

NEW LEAF VENTURE ASSOCIATES II, L.P.

NEW LEAF VENTURE MANAGEMENT II, L.L.C.

CHAMBON PHILIPPE O.

NIEDEL JAMES

HUNT RONALD

LATHI VIJAY K

DELAGARDELLE JEANI

RATCLIFFE LIAM

  • 10% Owner
1,680,475 2013-11-21 0

VIVO VENTURES V, LLC

VIVO VENTURES FUND V, L.P.

VIVO VENTURES V AFFILIATES FUND, L.P.

  • 10% Owner
180,015 2013-10-25 0

VIVO VENTURES VII, LLC

VIVO VENTURES FUND VII, L.P.

VIVO VENTURES VII AFFILIATES FUND, L.P.

  • 10% Owner
3,098,503 2013-10-25 0

NEW LEAF VENTURES II, L.P.

NEW LEAF VENTURE ASSOCIATES II, L.P.

NEW LEAF VENTURE MANAGEMENT II, L.L.C.

CHAMBON PHILIPPE O.

NIEDEL JAMES

HUNT RONALD

LATHI VIJAY K

DELAGARDELLE JEANI

  • 10% Owner
2,045,475 2013-05-06 0

NEW LEAF VENTURES II, L.P.

NEW LEAF VENTURE ASSOCIATES II, L.P.

NEW LEAF VENTURE MANAGEMENT II, L.L.C.

CHAMBON PHILIPPE O.

NIEDEL JAMES

HUNT RONALD

LATHI VIJAY K

DELAGARDELLE JEANI

AKKARAJU SRINIVAS

  • 10% Owner
2,502,775 2013-02-15 0

AUSTIN JOSIAH T

  • 10% Owner
0 2012-12-06 0

NOVOGEN LTD

  • 10% Owner
No longer subject to file 2012-12-03 0

AUSTIN JOSIAH T

EL CORONADO HOLDINGS, LLC

  • 10% Owner
3,832,081 2012-12-03 0

WILLIAMS BRYAN

  • Director
0 2012-09-21 0

JOHNSTON PHILIP A

  • Director
10,000 2009-05-18 0

SEATON DAVID R CFO & SECRETARY

  • Officer
5,000 2008-03-13 0

NAUGHTON CHRISTOPHER CEO & PRESIDENT

  • Officer
  • Director
5,000 2008-02-27 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GOLD DANIEL P PHD - Director - Officer CHIEF EXECUTIVE OFFICER

2021-07-06 18:47:33 -0400 2021-07-02 F 41,320 $2.94 d 417,312 direct 5.1282 -0.7326 9.5238 3 -0.7326 6

URSO DAVID M - Officer CHIEF OPERATING OFFICER & GC

2021-07-06 18:49:31 -0400 2021-07-02 F 24,825 $2.94 d 49,281 direct 5.1282 -0.7326 9.5238 3 -0.7326 6

REYNOLDS THOMAS C - Director

2021-07-06 19:02:37 -0400 2021-07-01 A 50,000 a 50,000 direct

CLEMENS KEVAN - Director

2021-07-06 18:55:50 -0400 2021-07-01 A 50,000 a 50,000 direct

DRAZBA BRIAN G. - Officer CHIEF FINANCIAL OFFICER

2021-07-06 18:51:14 -0400 2021-07-01 A 200,000 a 200,000 direct

WHITE CHRISTINE ANNA - Director

2021-07-06 19:03:43 -0400 2021-07-01 A 50,000 a 50,000 direct

DRISCOLL FREDERICK W - Director

2021-07-06 18:58:07 -0400 2021-07-01 A 50,000 a 50,000 direct

COHEN CHERYL - Director

2021-07-06 18:56:52 -0400 2021-07-01 A 50,000 a 50,000 direct

GHALIE RICHARD G - Officer CHIEF MEDICAL OFFICER

2021-07-06 18:52:56 -0400 2021-07-01 A 320,000 a 320,000 direct

GOLD DANIEL P PHD - Director - Officer CHIEF EXECUTIVE OFFICER

2021-07-06 18:47:33 -0400 2021-07-01 A 855,000 a 855,000 direct

HOWSON TAMAR D - Director

2021-07-06 19:00:43 -0400 2021-07-01 A 50,000 a 50,000 direct

GLOVER NICHOLAS - Director

2021-07-06 18:59:25 -0400 2021-07-01 A 50,000 a 50,000 direct

BALTIC CHARLES V. III - Director

2021-07-06 18:54:45 -0400 2021-07-01 A 50,000 a 50,000 direct

URSO DAVID M - Officer CHIEF OPERATING OFFICER & GC

2021-07-06 18:49:31 -0400 2021-07-01 A 600,000 a 600,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
MEI PHARMA INC MEIP 2021-07-23 22:15:03 UTC -0.3601 0.4401 1900000
MEI PHARMA INC MEIP 2021-07-23 21:45:03 UTC -0.3556 0.4356 1900000
MEI PHARMA INC MEIP 2021-07-23 21:15:03 UTC -0.3556 0.4356 1900000
MEI PHARMA INC MEIP 2021-07-23 20:45:03 UTC -0.3539 0.4339 1900000
MEI PHARMA INC MEIP 2021-07-23 20:15:05 UTC -0.3539 0.4339 1900000
MEI PHARMA INC MEIP 2021-07-23 19:45:03 UTC -0.3539 0.4339 1900000
MEI PHARMA INC MEIP 2021-07-23 19:15:03 UTC -0.3539 0.4339 1900000
MEI PHARMA INC MEIP 2021-07-23 18:45:03 UTC -0.3506 0.4306 1900000
MEI PHARMA INC MEIP 2021-07-23 18:15:03 UTC -0.3506 0.4306 1900000
MEI PHARMA INC MEIP 2021-07-23 17:45:03 UTC -0.3506 0.4306 1900000
MEI PHARMA INC MEIP 2021-07-23 17:15:02 UTC -0.3506 0.4306 1900000
MEI PHARMA INC MEIP 2021-07-23 16:45:02 UTC -0.3449 0.4249 1900000
MEI PHARMA INC MEIP 2021-07-23 16:15:03 UTC -0.3449 0.4249 1900000
MEI PHARMA INC MEIP 2021-07-23 15:45:02 UTC -0.3449 0.4249 1300000
MEI PHARMA INC MEIP 2021-07-23 15:15:03 UTC -0.3449 0.4249 1300000
MEI PHARMA INC MEIP 2021-07-23 14:45:03 UTC -0.2914 0.3714 1300000
MEI PHARMA INC MEIP 2021-07-23 14:15:03 UTC -0.2914 0.3714 1300000
MEI PHARMA INC MEIP 2021-07-23 13:45:03 UTC -0.2914 0.3714 1300000
MEI PHARMA INC MEIP 2021-07-23 13:15:03 UTC -0.2914 0.3714 1300000
MEI PHARMA INC MEIP 2021-07-23 12:45:03 UTC -0.2914 0.3714 1300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund MEIP -65817.0 shares, $-240232.05 2021-04-30 N-PORT

Elevate your investments